查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
Gene Panel市場 - 2018-2028F全球行業規模、佔有率、趨勢、機會和預測，按組件、技術、設計、應用、終端用戶、區域和競爭情況分類
市場調查報告書
商品編碼
1303129

Gene Panel市場 - 2018-2028F全球行業規模、佔有率、趨勢、機會和預測，按組件、技術、設計、應用、終端用戶、區域和競爭情況分類

Gene Panel Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Component, By Technique, By Design, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在預測期內，全球Gene Panel市場預計將見證令人印象深刻的成長。這可以歸因於唐氏症、鐮刀型紅血球疾病、stay-Sachs症等遺傳性疾病的日益流行。由於人們保健意識的提高和對早期診斷需求的增加，許多夫婦在計劃生育前或懷孕期間選擇基因檢測，進一步推動了預測期內的市場。由於技術的低成本和快速準確的測試，Gene Panel的應用越來越多，預計將推動市場成長。此外，不斷改善的醫療基礎設施，加上對Gene Panel相關研究和開發的投資不斷增加，預計在未來幾年將進一步為市場成長創造有利的機會。

慢性疾病的發病率不斷增加

癌症、先天性疾病、心臟病和關節炎等慢性疾病的發病率不斷上升，預計在預測期內，Gene Panel市場會有所成長。由於基因突變導致的疾病越來越多，需要進行Gene Panel測試。它是一種診斷技術，同時分析許多與癌症相關的基因改變。主要的關鍵參與者開發和推出癌症療法對Gene Panel的高需求，預計將在預測期內促進Gene Panel市場的成長。根據全球癌症觀察站的資料，全世界大約有19,292,789個新的癌症病例。其中，9,227,484個新的癌症病例是女性，而男性的新癌症病例數量約為10,065,305個。癌症發病率的成長將增加對Gene Panel的需求。鑑於成本高昂，基因檢測通常只對那些因遺傳性疾病而患特定類型癌症的高風險患者進行。這可能包括生活方式的因素，如吸煙、不健康的生活方式、體力活動減少和飲酒。根據世界衛生組織（WHO）的資料，全世界每年約有295 000名新生兒在出生後28天內因先天性畸形而死亡。

技術進步

對先進醫療檢測的需求不斷增加，加上臨床診斷中的個性化藥物，將在預測期內為市場成長創造有利的機會。目前，遺傳性疾病在老年人群中很常見，這為Gene Panel市場的成長提供了廣泛的支援。許多全球公司正致力於開發新的和先進的Gene Panel，這將進一步推動未來幾年的市場成長。許多私人和政府組織對開發新技術的計劃和投資不斷增加，這是推動市場成長的主要因素。每年在美國出生的每33個嬰兒中就有一個受到出生缺陷的影響，這意味著大約有12萬個嬰兒。

可用的客製化服務

利用給定的市場資料，TechSci Research根據公司的具體需要提供客製化服務。本報告可提供以下客製化選項：

公司資訊

  • 其他市場參與者（最多5家）的詳細分析和概況。

目錄

第一章：產品概述

  • 市場定義
  • 市場的範圍
    • 涵蓋的市場
    • 研究涵蓋的年份
    • 關鍵的市場細分

第二章：研究方法

  • 研究的目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二級來源
  • 預測方法
  • 資料三角測量和驗證
  • 假設和限制

第三章：執行摘要

  • 市場概述
  • 主要市場細分概述
  • 主要市場參與者概述
  • 主要地區/國家概況
  • 市場驅動因素、挑戰、趨勢概述

第四章：客戶的聲音

第五章：全球Gene Panel市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率與預測
    • 按成分（檢測試劑盒 v/s 檢測服務）分類
    • 按技術分類（基於擴增子的方法 v/s 基於雜交的方法）
    • 按設計（預先設計的Gene Panel v/s 客製化的Gene Panel）
    • 按應用（癌症風險評估、先天性疾病的診斷、藥物遺傳學、其他）
    • 按終端用戶（學術和研究機構、醫院和診斷實驗室、製藥和生物技術公司）分類
    • 按地區分類
    • 按公司分類(2022年)
  • 市場地圖
    • 按組件分類
    • 按技術分類
    • 按設計分類
    • 按應用分類
    • 按終端用戶分類
    • 按地區分類

第6章：北美Gene Panel市場前景

  • 市場規模和預測
    • 按價值分類
  • 市場佔有率與預測
    • 按成分分類
    • 按技術分類
    • 按設計分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • 北美洲：國家分析
    • 美國
    • 美國
    • 墨西哥

第七章：歐洲Gene Panel市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按成分分類
    • 按技術分類
    • 按設計分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區Gene Panel市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按成分分類
    • 按技術分類
    • 按設計分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第九章：南美Gene Panel市場展望

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率和預測
    • 按成分分類
    • 按技術分類
    • 按設計分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第十章：中東和非洲的Gene Panel市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率和預測
    • 按成分分類
    • 按技術分類
    • 按設計分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • MEA: 國家分析
    • 南非Gene Panel
    • 沙烏地阿拉伯Gene Panel
    • 阿拉伯聯合大公國Gene Panel

第11章：市場動態

  • 驅動力
  • 挑戰

第十二章：市場趨勢與發展

  • 最近的發展情況
  • 合併和收購
  • 產品發布

第十三章：競爭格局

  • 業務概況產品供應近期發展財務狀況（如報告所示） 主要人員SWOT分析
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fischer Scientific, Inc.
    • QIAGEN NV
    • Eurofins Scientific SE
    • Foundation Medicine Inc.
    • Guardant Health, Inc.
    • Myriad Genetic Laboratories Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche AG

第十四章：戰略建議

簡介目錄
Product Code: 14590

Global gene panel market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing prevalence of genetic disorders like Down syndrome, sickle cell disease, stay-Sachs disease, and others. Due to increasing healthcare awareness among the population and rising demand for early diagnosis, lots of couples opt for genetic testing before baby planning or during pregnancy, further boosting the market over the forecast period. Increasing application of gene panels owing to the low cost of the technique and fast and accurate testing is expected to propel market growth. Besides, improving healthcare infrastructure coupled with growing investments in research & development related to gene panels is further expected to create lucrative opportunities for market growth in the coming years.

Growing Incidence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, congenital diseases, heart attack, and arthritis is expected to grow in the gene panel market during the forecast period. Increasing disorders because of genetic mutation demand gene panel testing. It is a diagnostic technique that analyses many genes for cancer-associated alterations at the same time. High demand for gene panels by the major key players to develop and launch cancer therapy is expected to growth of the gene panel market over the forecast period. According to the global cancer observatory, around 19,292,789 new cancer cases were reported worldwide. Out of these, 9,227,484 new cancer cases were reported in females, while the number of new cancer cases reported in men was around 10,065,305. The growing prevalence of cancer will increase the demand for gene panels. Given the high cost, genetic testing is usually only carried out on patients who are at a high risk of developing specific types of cancer because of their heredity disorder. This may include lifestyle factors such as smoking, leading an unhealthy lifestyle, reduced physical activity, and alcohol consumption. According to World Health Organization (WHO), around 295 000 newborns die within 28 days of birth every year worldwide due to congenital anomalies.

Technological Advancements

Increasing demand for advanced medical testing, along with personalized medicines in clinical diagnosis, will create lucrative opportunities for market growth in the forecast period. Currently, genetic disorders are common in the geriatric population, which supports the gene panel market growth extensively. Many global companies are focusing on developing new and advanced gene panels, which is further expected to propel market growth over the coming years. Increasing initiative and investment by many private and government organizations for developing new technology is a major factor that boosts market growth. Birth defects affect 1 in every 33 babies born in the United States each year, which translates into about 120,000 babies.

Market Segmentation

The global gene panel market can be segmented by component, technique, design, application, end-user, and by region. Based on components, the market can be divided into Test Kits and Testing Services. Based on technique, the market can be divided into Amplicon Based Approach and Hybridization Based Approach. Based on the design, the market can be divided into Predesigned Gene Panels and Customized Gene Panels. Based on Application, the market can be segmented into Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, and Others. Based on end-user, the market can be differentiated into Academic & Research Institutes, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the Global Gene Panel Market on account of the growing demand for gene panel techniques for rising cases of cancer across the globe. A little over 1.9 million new cancer cases are expected to be diagnosed in the United States in 2022, according to the 2022 Cancer Facts & Figures report from the American Cancer Society (ACS).

Market Players

Illumina, Inc., Agilent Technologies, Inc., Thermo Fischer Scientific, Inc., QIAGEN NV, Eurofins Scientific SE, Foundation Medicine Inc., Guardant Health, Inc., Myriad Genetic Laboratories Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG are some of the leading players operating in the Global Gene Panel Market.

Report Scope

In this report, global gene panel market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Gene Panel Market, By Component:

  • Test Kits
  • Testing Services

Gene Panel Market, By Technique:

  • Amplicon Based Approach
  • Hybridization Based Approach

Gene Panel Market, By Design:

  • Predesigned Gene Panel
  • Customized Gene Panel

Gene Panel Market, By Application:

  • Cancer Risk Assessment
  • Diagnosis of Congenital Diseases
  • Pharmacogenetics
  • Others

Gene Panel Market, By End User:

  • Academic & Research Institutes
  • Hospital & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies

Gene Panel Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Gene Panel Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gene Panel Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Test Kits v/s Testing Services)
    • 5.2.2. By Technique (Amplicon Based Approach v/s Hybridization Based Approach)
    • 5.2.3. By Design (Predesigned Gene Panel v/s Customized Gene Panel)
    • 5.2.4. By Application (Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, Others)
    • 5.2.5. By End User (Academic & Research Institutes, Hospital & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies)
    • 5.2.6. By Region
    • 5.2.7. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Component
    • 5.3.2. By Technique
    • 5.3.3. By Design
    • 5.3.4. By Application
    • 5.3.5. By End User
    • 5.3.6. By Region

6. North America Gene Panel Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Technique
    • 6.2.3. By Design
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Gene Panel Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Design
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Gene Panel Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Design
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Gene Panel Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Design
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Gene Panel Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Technique
    • 7.2.3. By Design
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Gene Panel Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Design
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Germany Gene Panel Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Design
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Gene Panel Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Design
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Gene Panel Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Design
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Gene Panel Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Design
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia-Pacific Gene Panel Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Technique
    • 8.2.3. By Design
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Gene Panel Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Design
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Gene Panel Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Design
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Gene Panel Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Design
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Gene Panel Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Design
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Gene Panel Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Design
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. South America Gene Panel Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Technique
    • 9.2.3. By Design
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Gene Panel Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Design
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Gene Panel Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Design
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Gene Panel Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Design
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. Middle East and Africa Gene Panel Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Technique
    • 10.2.3. By Design
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Gene Panel Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Design
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Gene Panel Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Design
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Gene Panel Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Design
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. Illumina, Inc.
    • 13.6.2. Agilent Technologies, Inc.
    • 13.6.3. Thermo Fischer Scientific, Inc.
    • 13.6.4. QIAGEN NV
    • 13.6.5. Eurofins Scientific SE
    • 13.6.6. Foundation Medicine Inc.
    • 13.6.7. Guardant Health, Inc.
    • 13.6.8. Myriad Genetic Laboratories Inc.
    • 13.6.9. Bio-Rad Laboratories, Inc.
    • 13.6.10. F. Hoffmann-La Roche AG

14. Strategic Recommendations